Literature DB >> 20044211

Increased parasympathetic tone as the underlying cause of asthma: a hypothesis.

Manish Goyal1, Harinder Jaseja, Narsingh Verma.   

Abstract

Asthma is a chronic inflammatory disease of airways that is characterized by increased responsiveness of the tracheo-bronchial tree to multiple number of stimuli. Immunological theory does not explain all features in asthma, for example hyper-reactivity of the airways. Neurogenic theory also fails to explain the pathogenesis of asthma comprehensively. Higher parasympathetic tone has been reported in asthmatics but has never been suggested as a major underlying cause of asthma. This article attempts to explain the occurrence of hyper-responsiveness, inflammatory/allergic reactions and broncho-constriction in asthma on a common basis of inherent higher parasympathetic tone in asthmatics. The higher background parasympathetic firing leads to increased nitric oxide (NO) production owing to its co-localization with acetylcholine (ACh) in inhibitory non-adrenergic and non-cholinergic (i-NANC) nerves. NO is a neurotransmitter of i-NANC system and it mediates bronchodilation. Increased NO release has been found to be responsible for hyper-responsiveness and increased inflammation in the airways. The authors suggest that an inherently higher background parasympathetic tone in concert with inflammation or a specific genetic background could modify the effects of NO on lung homeostasis in humans leading to increased susceptibility to an asthmatic state. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20044211     DOI: 10.1016/j.mehy.2009.11.011

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  7 in total

1.  Associations between Parasympathetic Activity in the Month after Birth and Wheeze at Age 2-3 Years.

Authors:  Matthew S Perzanowski; Khalil W Savary; Emilio Arteaga-Solis; Laura A Lautenbacher; Natalie H Brito; Virginia A Rauh; J David Nugent; Amy J Elliott; Michael M Myers; William P Fifer
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

Review 2.  The new era of add-on asthma treatments: where do we stand?

Authors:  William J Calhoun; Geoffrey L Chupp
Journal:  Allergy Asthma Clin Immunol       Date:  2022-05-21       Impact factor: 3.373

Review 3.  Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?

Authors:  Denise L Bellinger; Dianne Lorton
Journal:  Int J Mol Sci       Date:  2018-04-13       Impact factor: 5.923

4.  Increased Heart Rate Variability Response Among Infants with Reported Rhinorrhea and Watery Eyes: A Pilot Study.

Authors:  Laura A Conrad; Natalie Buchinsky; Luis M Acosta; J David Nugent; Khalil W Savary; Rachel L Miller; Nurdant Emanet; Julie Herbstman; Beatrice Beebe; Michael M Myers; William P Fifer; Matthew S Perzanowski
Journal:  J Asthma Allergy       Date:  2021-11-09

5.  Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?

Authors:  David Price; Leonard Fromer; Alan Kaplan; Thys van der Molen; Miguel Román-Rodríguez
Journal:  NPJ Prim Care Respir Med       Date:  2014-07-17       Impact factor: 2.871

Review 6.  Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma.

Authors:  René Aalbers; Hae Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2017-09       Impact factor: 5.764

Review 7.  The evolving role of tiotropium in asthma.

Authors:  Emma R McIvor; R Andrew McIvor
Journal:  J Asthma Allergy       Date:  2017-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.